Skip to content
Open access

Isothermal miRNA Detection via Ligation-Dependent CRISPR/Cas13a Activation

Aug 2026 · ACS Omega · Vol 11, pp. 50040 - 50047 · 0 citations · 32 references
Medicine

TL;DR

A rapid isothermal strategy for miRNA detection based on ligation-dependent generation of Cas13a-activating RNA and CRISPR/Cas13a-mediated signal amplification that provides a useful framework for miRNA detection.

Abstract

Here, we present a rapid isothermal strategy for miRNA detection based on ligation-dependent generation of Cas13a-activating RNA and CRISPR/Cas13a-mediated signal amplification. The system employs two DNA probes: a hairpin-structured probe containing a double-stranded T7 promoter within its stem and a second probe encoding a template for Cas13a activator RNA. In the presence of a target miRNA, the probes are ligated to form a functional transcription template, enabling the generation of Cas13a-activating RNA. The resulting RNA activates the Cas13a–crRNA complex, inducing collateral cleavage of a fluorescent reporter for signal generation. The method achieves a limit of detection of 2.56 pM for miR-21 and 11.64 pM for miR-10a, with a linear response over 0–500 pM, while maintaining high specificity with negligible responses to nontarget miRNAs. Importantly, the entire assay is completed within 40 min at 37 °C, highlighting its rapid detection capability. The applicability of the platform is validated using miRNA extracted from HepG2, HeLa, and MCF-7 cells, yielding results consistent with RT-qPCR analysis. Owing to its short assay time, operation at 37 °C, and sequence programmability through probe redesign, this strategy provides a useful framework for miRNA detection.

Read PDF

Similar papers

Aug 2026

Orthogonal Cas13a/Cas12a cascade for one-pot amplification-free detection of miRNA-21.

MicroRNAs (miRNAs) are promising biomarkers for clinical diagnosis and disease monitoring. However, current CRISPR/Cas-based miRNA sensors generally require reverse transcription or nucleic acid amplification to improve sensitivity, which complicates the workflow and increases the risk of contamination, nonspecific amp...

Jing Yuan, Meng Shen, Li-Hua Ding et al. · 0 citations
Aug 2026

Programmable Allosteric DNAzyme Coupled with CRISPR/Cas12a System for Multiplexed and Sensitive Detection of Extracellular Vesicle Derived MicroRNAs

A previously unrecognized feature of CRISPR/Cas12a is identified, in which incorporation of ribonucleotides into single stranded DNA targets modulates Cas12a activation efficiency, revealing a hybrid DNA/RNA-dependent regulation of Cas12a activity.

Xiang-Lan He, Le Wang, Cong Zhang et al. · 0 citations
Sep 2026

RNase H-Assisted, Split-crRNA-Based CRISPR/Cas12a Lateral Flow Assay for Amplification-Free, Multi-Site Detection of Bacterial 16S rRNA

With the growing demand for on-site testing of foodborne pathogens, rapid and sensitive detection methods are urgently needed. Here, we developed a split-crRNA-based CRISPR/Cas12a assay integrated with a lateral flow assay (sCR-LFA) for rapid, sensitive detection of bacterial 16S rRNA within 1 h, without pre-amplific...

Yoo-Hong Min, Deok-Gyu Lee, Jin-Hee Yoo et al. · 0 citations
Open access Sep 2026

An RCA-Coupled CRISPR/Cas12a Cascade-Enhanced SERS Platform for Ultrasensitive Detection of Exosomal miRNA-21 in Colorectal Cancer Serum

Purpose Ultra-sensitive detection of exosomal miR-21 is crucial for the early diagnosis of colorectal cancer. This study aims to develop a cascade amplification platform based on surface-enhanced Raman scattering (SERS), combining rolling circle amplification (RCA) and CRISPR/Cas12a, to enable ultra-sensitive quantitat...

Jian Tao, Bin-Bin Zeng, Cai-Li Bi et al. · 0 citations
Sep 2026

A CRISPR/Cas9 multiplex nucleic acid sensing platform based on rolling circle amplification-mediated monomeric substrate generation.

The multiplex detection of nucleic acid biomarkers, including circulating tumor DNAs (ctDNAs) and microRNAs (miRNAs), holds promise for improving the accuracy of molecular diagnostic techniques. In this study, we developed a CRISPR/Cas9-based sensing platform capable of simultaneously detecting multiple nucleic acid bi...

Wei Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.